Adjunctive Ivermectin Mass Drug Administration for Malaria Control: A cluster randomised placebo-controlled trial (MATAMAL)
The main goal of this project is to investigate the impact of mass drug administration (MDA) with ivermectin on malaria transmission in a low-transmission setting.
All the islands will be given the standard control tools, such as bed nets. The "intervention" islands will also be given the drug, whereas the "control" islands, will not.
Phase 3 trial
Primary outcome: Population-based Plasmodium falciparum prevalence (all ages)